Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent publications published by researchers at the MRC WIMM.

Loss-of-Function Variants in SUPT5H as Modifying Factors in Beta-Thalassemia.

Journal article

Harteveld CL. et al, (2024), Int J Mol Sci, 25

The characteristics of CTCF binding sequences contribute to enhancer blocking activity.

Journal article

Tsang FH. et al, (2024), Nucleic Acids Res

Developing a pill to treat sickle cell disease.

Journal article

Higgs D. and Kassouf M., (2024), Science, 385, 27 - 28

Beginnings: The molecular pathology of hemoglobin

Chapter

Higgs D. and Badat M., (2024), Molecular Hematology, 1 - 16

Super-enhancers include classical enhancers and facilitators to fully activate gene expression.

Journal article

Blayney JW. et al, (2023), Cell, 186, 5826 - 5839.e18

RNA polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation.

Journal article

Martell DJ. et al, (2023), Dev Cell, 58, 2112 - 2127.e4

Ancient genomic linkage couples metabolism with erythroid development.

Journal article

Preston AE. et al, (2023), bioRxiv

Direct correction of haemoglobin E β-thalassaemia using base editors.

Journal article

Badat M. et al, (2023), Nat Commun, 14

Load More